deepeye
Munich
About deepeye
deepeye® is a precision medicine platform for retinal diseases. It enables ophthalmologists to provide individual therapy to patients suffering from prevalent eye diseases like Age-related Macular Degeneration (AMD) or other retinal diseases which affect 12% of the EU+US population, thus preventing the causes of more than 66% of blindness'.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $2.7M
- Funding stage: Seed
- Last round: Seed (Nov 2023)
- Website: deepeye-medical.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Medical Device, Software
Social Profiles
Canonical: https://fsome.com/organization/deepeye-72198 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.